Followers | 12 |
Posts | 470 |
Boards Moderated | 0 |
Alias Born | 06/20/2020 |
Wednesday, September 15, 2021 11:46:07 AM
We learned from the peer-reviewed scientific article that an IPIX employee or consultant was responsible for the following:
Conceptualization
Methodology
Visualization, Formal analysis, Data curation
Writing — original draft preparation
Writing — review and editing
Project administration
Funding acquisition
Where’s the “independent testing”? The only “independent” thing I see is that a lab technician at GMU (probably a student) did the bench work. IPIX was involved in the rest.
The pre-print omitted this information. It was the peer-review process that required disclosure. Since IPIX was involved in writing and review of the pre-print, one can reasonably conclude that it was their original intention to not reveal their involvement.
This does not mean that the data was invalid. I think I've made clear in several past posts that the data is valid and, unfortunately, does not bode well for success.
I've also written several times that this is not a bad time to be holding the stock because of the depressed share price/valuation, massive cash flooding the market, and abundance of uninformed investors.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM